Page 1512 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1512

Chapter 105Gastrointestinal HemorrhageRam Subramanian





                   REFERENCES

                    1. Zhao Y, Encinosa W.  Hospitalizations for Gastrointestinal     14. Cuellar RE, et al. Gastrointestinal tract hemorrhage. The
                      Bleeding in 1998 and 2006. HCUP Statistical Brief #65, December   value of a nasogastric aspirate. Arch Intern Med. 1990;150(7):
                      2008. Rockville, MD: Agency for Healthcare Research and   1381-1384.
                      Quality; 2008.                                       15. Palamidessi N, et al. Nasogastric aspiration and lavage in
                    2. Gralnek IM, Barkun AN, Bardou M. Management of acute   emergency department patients with hematochezia or melena
                      bleeding from a peptic ulcer.  N Engl J Med. 2008;359(9):   without hematemesis. Acad Emerg Med. 2010;17(2):126-132.
                      928-937.                                             16. Barkun AN. International consensus recommendations on the
                    3. Farrell JJ, Friedman LS. Gastrointestinal bleeding in older   management of patients with nonvariceal upper gastrointestinal
                      people. Gastroenterol Clin North Am. 2000;29(1):1-36, v.  bleeding. Ann Intern Med. 2010;152:101-113.
                    4. Lim CH, et al. The outcome of suspected upper gastrointes-    17. Jensen DM, Machicado GA. Colonoscopy for diagnosis and
                      tinal bleeding with 24-hour access to upper gastrointestinal   treatment of severe lower gastrointestinal bleeding: routine
                      endoscopy: a prospective cohort study. Endoscopy. 2006;38(6):   outcomes and cost analysis.  Gastrointest Endosc Clin N Am.
                      581-585.                                               1997;7(3):477-498.
                    5. Lewis JD, et al. Hospitalization and mortality rates from peptic     18. Jensen DM. et al. Urgent colonoscopy for the diagnosis and
                      ulcer disease and GI bleeding in the 1990s: relationship to sales   treatment of severe diverticular hemorrhage.  N Engl J Med.
                      of nonsteroidal anti-inflammatory drugs and acid suppression   2000;342(2):78-82.
                      medications. Am J Gastroenterol. 2002;97(10):2540-2549.    19. Laine L, Shah A. Randomized trial of urgent vs. elective colo-
                    6. Barkun  A,  et  al.  The  canadian  registry  on  nonvariceal  upper   noscopy in patients hospitalized with lower GI bleeding. Am J
                      gastrointestinal bleeding and endoscopy (RUGBE): endoscopic   Gastroenterol. 2010;105(12):2636-2641.
                      hemostasis and proton pump inhibition are associated with     20. Frossard JL, et al. Erythromycin intravenous bolus infusion in
                      improved outcomes in a real-life setting.  Am J Gastroenterol.   acute upper gastrointestinal bleeding: a randomized, controlled,
                      2004;99(7):1238-1246.                                  double-blind trial. Gastroenterology. 2002;123(1):17-23.
                    7. Kollef MH, et al. BLEED: a classification tool to predict out-    21. Barkun AN, Bardou M, Gralnek IM. W1017 erythromycin and
                      comes in patients with acute upper and lower gastrointestinal   other prokinetics in acute upper gastrointestinal bleeding? A
                      hemorrhage. Crit Care Med. 1997;25(7):1125-1132.       meta-analysis. Gastroenterology. 2009;136(5 suppl 1):A-636.
                    8. Rockall TA, et al. Risk assessment after acute upper gastrointes-    22. Lau JY, et al. Effect of intravenous omeprazole on recurrent
                      tinal haemorrhage. Gut. 1996;38(3):316-321.            bleeding after endoscopic treatment of bleeding peptic ulcers.
                    9. Corley DA, et al. Early indicators of prognosis in upper gastro-  N Engl J Med. 2000;343(5):310-316.
                      intestinal hemorrhage. Am J Gastroenterol. 1998;93(3):336-340.    23. Ejlersen E, et al. Recombinant activated factor VII (rFVIIa)
                   10. Kuipers EJ. Endoscopy: risk assessment in upper gastrointesti-  acutely normalizes prothrombin time in patients with cirrhosis
                      nal bleeding. Nat Rev Gastroenterol Hepatol. 2010;7(9):480-482.  during bleeding from oesophageal varices. Scand J Gastroenterol.
                   11. Velayos FS, et al. Early predictors of severe lower gastrointes-  2001;36(10):1081-1085.
                      tinal bleeding and adverse outcomes: a prospective study. Clin     24. Negrier C, Lienhart A. Overall experience with NovoSeven.
                      Gastroenterol Hepatol. 2004;2(6):485-490.              Blood Coagul Fibrinolysis. 2000;11(suppl 1):S19-S24.
                   12. Strate LL, Orav EJ, Syngal S. Early predictors of severity     25. Bosch J, et al. Recombinant factor VIIa for upper gastrointesti-
                      in acute lower intestinal tract bleeding.  Arch Intern Med.   nal bleeding in patients with cirrhosis: a randomized, double-
                      2003;163(7):838-843.                                   blind trial. Gastroenterology. 2004;127(4):1123-1130.
                   13. Strate LL, et al. Validation of a clinical prediction rule for     26. Bosch J, et al. Recombinant factor VIIa for variceal bleeding in
                      severe acute lower intestinal bleeding.  Am J Gastroenterol.   patients with advanced cirrhosis: a randomized, controlled trial.
                      2005;100(8):1821-1827.                                 Hepatology. 2008;47(5):1604-1614.











          Section09-O-Ref.indd   1                                                                                  12/10/2014   6:09:24 PM
   1507   1508   1509   1510   1511   1512   1513   1514   1515   1516   1517